Guillot Morales, Mónica http://orcid.org/0000-0001-7509-146X
Visa, Laura
Brozos Vázquez, Elena
Feliu Batlle, Jaime
Khosravi Shahi, Parham
Laquente Sáez, Berta
de San Vicente Hernández, Borja López
Macarulla, Teresa
Gironés Sarrió, Regina
Article History
Received: 19 December 2023
Accepted: 4 January 2024
First Online: 8 February 2024
Declarations
:
: Mónica Guillot Morales has received consultancy or advisory honoraria from GlaxoSmithKline and Roche; speaking and public presentations on behalf of Merck KGaA and Roche; and travel and accommodations expenses from Amgen and Servier. Laura Visa has received consultancy or advisory honoraria from Bristol-Myers Squibb; speaking and public presentations on behalf of AstraZeneca and Bristol-Myers Squibb; and travel and accommodations expenses from AstraZeneca. Elena Brozos Vázquez has received consultancy or advisory honoraria from Bayer, Pfizer, and Servier; travel and accommodations expenses from Amgen, Eli Lilly and Company, Daiichi Sankyo, LEO Pharma, Merck, Pfizer, Roche, Rovi, Sanofi, and Servier; payment or honoraria for educational activities from Amgen, Bayer, Kyowa Kirin, LEO Pharma, Merck, Pierre Fabre, Rovi, Roche, and Sanofi. Jaime Feliu Batlle has received consultancy or advisory honoraria from Amgen, AstraZeneca, Ipsen, Novartis, Roche, and Viatris; and research funding from Amgen and Merck Sharp & Dohme. Parham Khosravi Shahi declares no conflict of interest. Berta Laquente Saez has received consultancy and advisory honoraria, honoraria from speaking and public presentations, and travel and accommodations expenses from AstraZeneca. Borja López de San Vicente Hernández has received consultancy and advisory honoraria from Bristol-Myers Squibb, Eisai, and Servier; and travel and accommodation expenses from Ipsen, Merck KGaA, and Merck Sharp & Dohme. Teresa Macarulla has received consultancy and advisory honoraria from Ability Pharma, AstraZeneca, Basilea Pharmaceutica, Baxter, BioLineRx Ltd, Celgene, Eisai, Incyte, and Ipsen; speaking and public presentations on behalf of Eli Lilly and Company and Janssen; travel and accommodations expenses from AstraZeneca, Eli Lilly and Company, Incyte, Merck Sharp & Dohme, Sanofi and Servier; and research funding from Merck Sharp & Dohme, Novocure, QED Therapeutics, Roche, Sanofi, Servier, and Zymeworks. Regina Gironés Sarrió has made speaking and public presentations on behalf of AstraZeneca, Bristol-Myers Squibb, Ipsen, Novocure, Pfizer, and Roche.
: Not applicable.
: Not applicable.
: Not applicable.